ARCHIVES

Two Phase III Afatinib Trials Demonstrate Prolonged Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group Meetings for July

June 27, 1975

In Brief :Three Named to Leadership Posts At St. Jude; Mitchell Weiss Appointed Chair of Hematology

June 11, 2014

Karen Antman recruited to NCI on an IPA to oversee changes to centers, SPORE programs.

October 31, 2003

ORI Finds Misconduct By CIT Professor

August 4, 1995

Preoperative Chemo Doubles Survival In Locally Advanced Bladder Cancer

May 25, 2001

DCT Board Ok’s PA, BRM Contract Concepts

October 30, 1992